Literature DB >> 25409949

Impact of elevated serum estradiol/free testosterone ratio on male varicose veins in a prospective study.

Sedat Özcan1, Dolunay Odabasi2, Tolga Kurt3, Ali Kemal Gür2, Aysegul Kunt2, Yavuz Balaharoglu4, Alper Sami Kunt2.   

Abstract

OBJECTIVE: Although some studies indicate an association between increased levels of estradiol and varicose veins in women, the role of sex hormones on varicose veins have a question mark in men.
METHODS: We investigated estradiol-2/free testosterone (E2/fT) ratio relationship on varicosity in 100 male patients dividing them into two groups. Group A (n = 46) had varicose veins with endocrinological problems, especially infertility, whereas group B (n = 54) also had varicose veins but no endocrinological problems. Venous blood samples were drawn from both groups in the morning to detect the levels of serum estradiol (E2), androstenedione, dehydroepiandrostenedione sulphate and free testosterone (fT). Patient history, physical examination, colour duplex ultrasound of both limbs and classification of CEAP were performed in both groups. Serum E2/fT ratio was calculated in correspondence with CEAP classification. CEAP classification is the varicosity classification, and it is concerned about the clinical class (C), etiology (E), anatomical distribution (A) and underlying pathophysiology (P).
RESULTS: E2/fT ratio was significantly higher in group A (4.18 ± 0.54) compared with group B (2.98 ± 0.36). Moreover, there is a high correlation between serum E2/fT ratio and CEAP clinical classification in group A (4) compared with group B (2).
CONCLUSION: Serum E2/fT ratio is associated with varicose veins in male patients.

Entities:  

Keywords:  CEAP classification; Chronic venous insufficiency; Sex hormones; Varicose veins

Mesh:

Substances:

Year:  2014        PMID: 25409949     DOI: 10.1007/s00508-014-0652-z

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  23 in total

Review 1.  Clinical review 110: Cardiovascular actions of estrogens in men.

Authors:  K Sudhir; P A Komesaroff
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

2.  Changes in the extracellular matrix of the vein wall--the cause of primary varicosis?

Authors:  D Kirsch; H P Dienes; R Küchle; H Duschner; W Wahl; T Böttger; T Junginger
Journal:  Vasa       Date:  2000-08       Impact factor: 1.961

Review 3.  The epidemiology of chronic venous insufficiency and varicose veins.

Authors:  Jennifer L Beebe-Dimmer; John R Pfeifer; Jennifer S Engle; David Schottenfeld
Journal:  Ann Epidemiol       Date:  2005-03       Impact factor: 3.797

4.  Decreased fertility in men with venous stasis of the legs.

Authors:  R G Howell; J L Burton
Journal:  Lancet       Date:  1982-09-18       Impact factor: 79.321

Review 5.  Nuclear receptors and lipid physiology: opening the X-files.

Authors:  A Chawla; J J Repa; R M Evans; D J Mangelsdorf
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

6.  Estrogen and progesterone inhibit vascular smooth muscle proliferation.

Authors:  A K Morey; A Pedram; M Razandi; B A Prins; R M Hu; E Biesiada; E R Levin
Journal:  Endocrinology       Date:  1997-08       Impact factor: 4.736

7.  High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women.

Authors:  A V Ciardullo; S Panico; C Bellati; P Rubba; S Rinaldi; A Iannuzzi; V Cioffi; G Iannuzzo; F Berrino
Journal:  J Vasc Surg       Date:  2000-09       Impact factor: 4.268

Review 8.  Venous disease: from pathophysiology to quality of life.

Authors:  P M Vanhoutte; S Corcaud; C de Montrion
Journal:  Angiology       Date:  1997-07       Impact factor: 3.619

9.  Prevalence and risk factors of varicose veins in lower extremities: mini-Finland health survey.

Authors:  T Sisto; A Reunanen; J Laurikka; O Impivaara; M Heliövaara; P Knekt; A Aromaa
Journal:  Eur J Surg       Date:  1995-06

10.  Endogenous hormones and carotid atherosclerosis in elderly men.

Authors:  A W van den Beld; M L Bots; J A M L L Janssen; H A P Pols; S W J Lamberts; D E Grobbee
Journal:  Am J Epidemiol       Date:  2003-01-01       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.